<DOC>
	<DOCNO>NCT01155518</DOCNO>
	<brief_summary>Low testosterone production , know clinically hypogonadism , appear common complication type 2 diabetes , affect one three diabetic men . Hypogonadism know associate decreased muscle mass , increase fat mass , increase inflammation decrease fertility . In grant , investigator propose study effect low testosterone 1 ) insulin sensitivity , ability body handle glucose 2 ) fat muscle mass specific area body 3 ) expression mediator inflammation blood 4 ) semen quality . This study compare diabetic men ( without hypogonadism ) . This study also evaluate effect treatment clomiphene ( drug increase testosterone sperm production ) testosterone men diabetes hypogonadism . The investigator hope project help u understand state hypogonadism young type 2 diabetic men peak fertility year give u insights treatment condition . With rise prevalence type 2 diabetes young , project may implications public health .</brief_summary>
	<brief_title>Hypogonadism Young Men With Type 2 Diabetes</brief_title>
	<detailed_description>This project study young men type 2 diabetes . We show half men low testosterone level . This lead 1 ) Low muscle mass ; 2 ) fat mass ; 3 ) insulin resistance ; 4 ) low sperm count 5 ) increase inflammation ( increase risk heart disease ) . This project study consequence detail also possibility reverse treatment . Information project useful planning future study evaluate effect treatment low testosterone mortality , heart disease stroke .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>T2D Males age 1840 year 1. plan child next one year 2 . Use androgen , CC , hCG , aromatase inhibitor counter health supplement contain androgen currently past 6 month ; 3 . PSA &gt; 4ng/ml , symptom severe BPH , prostate nodule severe enlargement digital rectal examination h/o prostatic carcinoma 4 . Hemoglobin A1c &gt; 8 % 5 . Hematocrit &gt; 50 % 6 . History obstructive sleep apnea 7 . Congestive heart failure 8 . Use thiazolidinediones exenatide 9. currently suffer depression , without treatment 10. history severe depression past need hospitalization 11. currently suffer foot ulcer , significant periodontal disease chronic infectious condition 12 . Coronary event procedure previous 6 month 13 . Hepatic disease ( transaminase &gt; 3 time normal ) cirrhosis 14 . Renal impairment ( serum creatinine &gt; 1.5 ) 15 . HIV Hepatitis C positive status 16 . Participation concurrent clinical trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>diabetes</keyword>
	<keyword>spermatogenesis</keyword>
	<keyword>insulin resistance</keyword>
</DOC>